دورية أكاديمية
Relationship Between Tobacco Product Use and Health-Related Quality of Life Among Individuals With COPD in Waves 1-5 (2013-2019) of the Population Assessment of Tobacco and Health Study.
العنوان: | Relationship Between Tobacco Product Use and Health-Related Quality of Life Among Individuals With COPD in Waves 1-5 (2013-2019) of the Population Assessment of Tobacco and Health Study. |
---|---|
المؤلفون: | Paulin LM; Geisel School of Medicine at Dartmouth, The C. Everett Koop Institute at Dartmouth, Hanover, New Hampshire, United States., Halenar MJ; Behavioral Health and Health Policy Practice, Westat, Rockville, Maryland, United States., Edwards KC; Behavioral Health and Health Policy Practice, Westat, Rockville, Maryland, United States., Lauten K; Behavioral Health and Health Policy Practice, Westat, Rockville, Maryland, United States., Taylor K; Behavioral Health and Health Policy Practice, Westat, Rockville, Maryland, United States., Brunette M; Geisel School of Medicine at Dartmouth, The C. Everett Koop Institute at Dartmouth, Hanover, New Hampshire, United States., Tanski S; Geisel School of Medicine at Dartmouth, The C. Everett Koop Institute at Dartmouth, Hanover, New Hampshire, United States., MacKenzie T; Geisel School of Medicine at Dartmouth, The C. Everett Koop Institute at Dartmouth, Hanover, New Hampshire, United States., Stanton CA; Behavioral Health and Health Policy Practice, Westat, Rockville, Maryland, United States., Hatsukami D; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, United States., Hyland A; Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States., Mahoney MC; Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States., Niaura R; School of Global Public Health, New York University, New York, New York, United States., Trinidad D; University of California at San Diego, La Jolla, California, United States., Blanco C; National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland, United States., Compton W; National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland, United States., Gardner LD; Center for Tobacco Products, Food and Drug Administration, Silver Spring, Maryland, United States., Kimmel HL; National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland, United States., Cummings KM; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, United States., Lauterstein D; Center for Tobacco Products, Food and Drug Administration, Silver Spring, Maryland, United States., Roh EJ; Center for Tobacco Products, Food and Drug Administration, Silver Spring, Maryland, United States., Marshall D; National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland, United States.; Axle Informatics, Rockville, Maryland, United States., Sargent JD; Geisel School of Medicine at Dartmouth, The C. Everett Koop Institute at Dartmouth, Hanover, New Hampshire, United States. |
المصدر: | Chronic obstructive pulmonary diseases (Miami, Fla.) [Chronic Obstr Pulm Dis] 2024 Jan 25; Vol. 11 (1), pp. 68-82. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: COPD Foundation Country of Publication: United States NLM ID: 101635411 Publication Model: Print Cited Medium: Print ISSN: 2372-952X (Print) Linking ISSN: 2372952X NLM ISO Abbreviation: Chronic Obstr Pulm Dis Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Publication: <2015-> : Denver, CO : COPD Foundation Original Publication: Miami, FL : COPD Foundation, [2014]- |
مستخلص: | Introduction: We examined the association between tobacco product use and health-related quality of life (HRQoL) among individuals with chronic obstructive pulmonary disease (COPD) in Waves 1-5 of the Population Assessment of Tobacco and Health (PATH) Study. Methods: Adults ≥40 years with an ever COPD diagnosis were included in cross-sectional (Wave 5) and longitudinal (Waves 1 to 5) analyses. Tobacco use included 13 mutually exclusive categories of past 30-day (P30D) single use and polyuse with P30D exclusive cigarette use and ≥5-year cigarette cessation as reference groups. Multivariable linear regression and generalized estimating equations (GEE) were used to examine the association between tobacco use and HRQoL as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Global-10 questionnaire. Results: Of 1670 adults, 79.4% ever used cigarettes; mean (standard error [SE]) pack years was 30.9 (1.1). In cross-sectional analysis, P30D exclusive cigarette use, and e-cigarette/cigarette dual use were associated with worse HRQoL compared to ≥5-year cigarette cessation. Compared to P30D exclusive cigarette use, never tobacco use and ≥5-year cigarette cessation were associated with better HRQoL, while e-cigarette/cigarette dual use had worse HRQoL. Longitudinally (n=686), e-cigarette/cigarette dual use was associated with worsening HRQoL compared to both reference groups. Only never tobacco use was associated with higher HRQoL over time compared to P30D exclusive cigarette use. Conclusions: E-cigarette/cigarette dual use was associated with worse HRQoL compared to ≥5-year cigarette cessation and exclusive cigarette use. Never use and ≥5-year cigarette cessation were the only categories associated with higher HRQoL compared to exclusive cigarette use. Findings highlight the importance of complete smoking cessation for individuals with COPD. (JCOPDF © 2024.) |
التعليقات: | Erratum in: Chronic Obstr Pulm Dis. 2024 Jul 24;11(4):436. doi: 10.15326/jcopdf.2023.0422E. (PMID: 39048097) |
References: | Qual Life Res. 2009 Sep;18(7):873-80. (PMID: 19543809) Ann Intern Med. 2018 Jul 17;169(2):106-115. (PMID: 29971337) Thorax. 2014 May;69(5):491-4. (PMID: 24029743) PLoS One. 2014 Dec 16;9(12):e114438. (PMID: 25514500) Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):381-90. (PMID: 10673175) Am J Respir Crit Care Med. 2019 Nov 15;200(10):1195-1197. (PMID: 31513746) BMC Pulm Med. 2011 Jun 14;11:36. (PMID: 21672193) PLoS One. 2014 Mar 17;9(3):e91562. (PMID: 24637739) Qual Life Res. 2015 Apr;24(4):999-1009. (PMID: 25307510) Nicotine Tob Res. 2008 May;10(5):843-50. (PMID: 18569758) Tob Control. 2020 May;29(Suppl 3):s139-s146. (PMID: 32321847) BMC Public Health. 2015 Sep 04;15:859. (PMID: 26341634) Med Care. 2007 May;45(5 Suppl 1):S3-S11. (PMID: 17443116) Tob Regul Sci. 2021 Jan;7(1):3-16. (PMID: 33860066) Am J Respir Crit Care Med. 2018 Nov 1;198(9):1130-1139. (PMID: 29979608) Psychol Med. 2014 Sep;44(12):2523-35. (PMID: 25055171) Am J Epidemiol. 2020 Dec 1;189(12):1529-1537. (PMID: 32715314) Ann Am Thorac Soc. 2020 Jul;17(7):804-806. (PMID: 32348693) Am J Respir Crit Care Med. 2019 Nov 15;200(10):1228-1233. (PMID: 31348686) Vital Health Stat 2. 1969 Jan;(31):1-24. (PMID: 5306564) Am J Addict. 2017 Jan;26(1):8-25. (PMID: 28000973) Nicotine Tob Res. 2022 Oct 17;24(10):1607-1618. (PMID: 35366322) JAMA Netw Open. 2019 Nov 1;2(11):e1915494. (PMID: 31730180) Addiction. 2019 Oct;114 Suppl 1:49-60. (PMID: 31225672) CMAJ. 2009 Apr 14;180(8):814-20. (PMID: 19364790) BMC Med Res Methodol. 2014 Jun 16;14:78. (PMID: 24934150) Psychol Med. 2017 Sep;47(12):2097-2106. (PMID: 28399956) Addiction. 2010 Aug;105(8):1466-71. (PMID: 20528815) Thorax. 2004 May;59(5):387-95. (PMID: 15115864) Medicine (Baltimore). 2019 Nov;98(46):e17996. (PMID: 31725666) Thorax. 2016 Mar 9;71:411-420. (PMID: 26962015) Arch Intern Med. 2007 Dec 10;167(22):2516-23. (PMID: 18071176) EC Pulmonol Respir Med. 2018;7(9):650-662. (PMID: 30294723) Int J Chron Obstruct Pulmon Dis. 2014 May 14;9:493-8. (PMID: 24868154) Med Cannabis Cannabinoids. 2021 Aug 12;4(2):114-120. (PMID: 35224431) Breathe (Sheff). 2019 Mar;15(1):24-35. (PMID: 30838057) Tob Control. 2019 Nov;28(6):663-668. (PMID: 30297373) Tob Control. 2017 Jul;26(4):371-378. (PMID: 27507901) Am J Prev Med. 2022 Apr;62(4):492-502. (PMID: 35120768) Curr Addict Rep. 2017 Jun;4(2):100-109. (PMID: 29062679) Respir Res. 2013 Oct 09;14:103. (PMID: 24107140) N Engl J Med. 2013 Jan 24;368(4):341-50. (PMID: 23343063) Int J Chron Obstruct Pulmon Dis. 2009;4:169-76. (PMID: 19516915) Expert Rev Respir Med. 2016;10(3):351-62. (PMID: 26808786) Prev Med. 2017 Nov;104:13-23. (PMID: 28705601) Ther Adv Chronic Dis. 2020 Oct 10;11:2040622320961617. (PMID: 33101622) COPD. 2010 Feb;7(1):32-43. (PMID: 20214461) Thorax. 2002 Nov;57(11):967-72. (PMID: 12403880) Int J Chron Obstruct Pulmon Dis. 2011;6:259-67. (PMID: 21814462) |
معلومات مُعتمدة: | HHSN27101100027C NIH NIDA; HHSN27101100027C FDA CTP; HHSN27120160001C NIH NIDA; HHSN27120160001C FDA CTP |
فهرسة مساهمة: | Keywords: COPD; cigarette; e-cigarette; epidemiology; prevention |
تواريخ الأحداث: | Date Created: 20231219 Latest Revision: 20240724 |
رمز التحديث: | 20240726 |
مُعرف محوري في PubMed: | PMC10913919 |
DOI: | 10.15326/jcopdf.2023.0422 |
PMID: | 38113525 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2372-952X |
---|---|
DOI: | 10.15326/jcopdf.2023.0422 |